NASDAQ: CVKD
Cadrenal Therapeutics Inc Stock Ownership - Who owns Cadrenal Therapeutics?

Insider buying vs selling

Have Cadrenal Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Quang X. PhamChairman CEO and Interim CFO2026-06-103,500$4.21
$14.74kSell
Quang X. PhamChairman CEO and Interim CFO2026-06-0912,992$4.06
$52.75kSell
Quang X. PhamChairman CEO and Interim CFO2026-06-085,893$4.38
$25.81kSell
Quang X. PhamCEO and Chairman2026-06-052,064$4.42
$9.12kSell
Quang X. PhamCEO and Chairman2026-06-043,898$4.41
$17.19kSell
Quang X. PhamCEO and Chairman2026-06-032,323$4.26
$9.90kSell
Quang X. PhamCEO and Chairman2026-06-02349$4.46
$1.56kSell
Quang X. PhamCEO and Chairman2026-05-29303$5.01
$1.52kSell
Quang X. PhamCEO and Chairman2026-05-282,989$4.93
$14.74kSell
Quang X. PhamCEO and Chairman2026-05-221,165$5.69
$6.63kSell

1 of 4

CVKD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CVKD insiders and whales buy or sell their stock.

CVKD Shareholders

What type of owners hold Cadrenal Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
John Raymond Murphy21.43%614,792$2.27MInsider
Quang X. Pham12.23%350,839$1.30MInsider
Glynn Wilson1.74%50,000$185.00kInsider
Vanguard Capital Management LLC1.58%45,201$167.24kInstitution
Steven Zelenkofske1.39%40,000$148.00kInsider
Geode Capital Management LLC0.75%21,626$80.02kInstitution
Vanguard Fiduciary Trust Co0.29%8,311$30.75kInstitution
Jpmorgan Chase Co0.26%7,500$27.75kInstitution
Blackrock Inc0.19%5,496$20.34kInstitution
Lee Scott Golden0.06%1,667$6.17kInsider

1 of 3

CVKD vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CVKD3.18%36.86%Net SellingNet Selling
CURX1.16%8.68%
BCDA0.35%99.65%Net BuyingNet Buying
IMRN0.03%1.91%
KAPA2.81%35.51%

Cadrenal Therapeutics Stock Ownership FAQ

Who owns Cadrenal Therapeutics?

Cadrenal Therapeutics (NASDAQ: CVKD) is owned by 3.18% institutional shareholders, 36.86% Cadrenal Therapeutics insiders, and 59.96% retail investors. John Raymond Murphy is the largest individual Cadrenal Therapeutics shareholder, owning 614,792.00 shares representing 21.43% of the company. John Raymond Murphy's Cadrenal Therapeutics shares are currently valued at $2.05M.

If you're new to stock investing, here's how to buy Cadrenal Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.